300966 Hubei Goto Biopharm
- 16.46
- +0.12+0.73%
Hubei Goto Biopharm News
Hubei Goto Biopharm: Legal opinion from Beijing Zhonglun (Wuhan) Law Firm regarding the 2024 second extraordinary general meeting of shareholders of Hubei Jointown Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: Announcement of resolution of the Second Extraordinary Shareholders' Meeting in 2024.
Hubei Goto Biopharm: Announcement regarding not downwardly revising the price of debt-for-equity swaps.
Hubei Goto Biopharm: Announcement of the resolution of the 26th meeting of the 2nd board of directors
Hubei Goto Biopharm: Announcement regarding the expiration of the shareholding reduction plan for shareholders and directors holding more than 5% of the shares.
Hubei Goto Biopharm: Announcement on the conditions for downward revision of the expected conversion price of convertible bonds.
Hubei Goto Biopharm: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Hubei Goto Biopharm: Announcement regarding the wholly-owned subsidiary's plan to apply for a comprehensive credit limit from banks and the company providing guarantee for it.
Hubei Goto Biopharm: Announcement of Resolution of the 25th Meeting of the Second Board of Directors.
Hubei Goto Biopharm: Announcement regarding cumulative new loans exceeding 20% of net assets at the end of the previous year.
Hubei Goto Biopharm: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.
Hubei Goto Biopharm: Announcement on the Progress of Providing Guarantees for Applying for Comprehensive Credit Lines for Subsidiaries.
Hubei Goto Biopharm: Hubei Jointown Pharmaceutical Group Co., Ltd.'s Main and Convertible Bonds 2024 Tracking Rating Report.
Hubei Goto Biopharm: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 First Temporary Shareholders' Meeting of Hubei Jointown Pharmaceutical Co., Ltd.
Hubei Goto Biopharm: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hubei Goto Biopharm: CSI Enterprise Bond Index issued convertible corporate bonds to unspecified entities in Hubei and entrusted management affairs report (2023).
Hubei Goto Biopharm: Announcement regarding the adjustment of the conversion price for convertible bonds into shares.
Hubei Goto Biopharm: Announcement of the implementation of equity distribution in 2023.
Hubei Goto Biopharm: Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Hubei Goto Biopharm: Announcement of Resolutions of the 24th Meeting of the 2nd Board of Directors
Analysis
Price Target
No Data
